These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22273841)

  • 61. Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts.
    Fairchild RL; VanBuskirk AM; Kondo T; Wakely ME; Orosz CG
    Transplantation; 1997 Jun; 63(12):1807-12. PubMed ID: 9210509
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
    Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection.
    Bharat A; Narayanan K; Street T; Fields RC; Steward N; Aloush A; Meyers B; Schuessler R; Trulock EP; Patterson GA; Mohanakumar T
    Transplantation; 2007 Jan; 83(2):150-8. PubMed ID: 17264811
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative study on signal transduction in endothelial cells after anti-a/b and human leukocyte antigen antibody reaction: implication of accommodation.
    Iwasaki K; Miwa Y; Ogawa H; Yazaki S; Iwamoto M; Furusawa T; Onishi A; Kuzuya T; Haneda M; Watarai Y; Uchida K; Kobayashi T
    Transplantation; 2012 Feb; 93(4):390-7. PubMed ID: 22222784
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection.
    Takenaka M; Subramanian V; Tiriveedhi V; Phelan D; Hachem R; Trulock E; Gelman AE; Patterson GA; Hoshinaga K; Mohanakumar T
    J Heart Lung Transplant; 2012 Nov; 31(11):1214-22. PubMed ID: 22980951
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pretransplant serum BAFF levels are associated with pretransplant HLA immunization and renal allograft survival.
    Friebus-Kardash J; Wilde B; Keles D; Heinold A; Kribben A; Witzke O; Heinemann FM; Eisenberger U
    Transpl Immunol; 2018 Apr; 47():10-17. PubMed ID: 29277566
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy.
    Nath DS; Ilias Basha H; Tiriveedhi V; Alur C; Phelan D; Ewald GA; Moazami N; Mohanakumar T
    J Heart Lung Transplant; 2010 Nov; 29(11):1277-85. PubMed ID: 20615726
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Transient blockade of delta-like Notch ligands prevents allograft rejection mediated by cellular and humoral mechanisms in a mouse model of heart transplantation.
    Wood S; Feng J; Chung J; Radojcic V; Sandy-Sloat AR; Friedman A; Shelton A; Yan M; Siebel CW; Bishop DK; Maillard I
    J Immunol; 2015 Mar; 194(6):2899-908. PubMed ID: 25687759
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients.
    Nozaki T; Amano H; Bickerstaff A; Orosz CG; Novick AC; Tanabe K; Fairchild RL
    J Immunol; 2007 Oct; 179(8):5238-45. PubMed ID: 17911609
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gene transfer of the S24F regulated on activation normal T-cell expressed and secreted-chemokine ligand 5 variant attenuates cardiac allograft rejection.
    Sun Y; Feng J; Shi J; Lu X; Xie A; Chen Y; Dong N
    Transplantation; 2014 Jun; 97(12):1233-9. PubMed ID: 24825519
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective crossmatch.
    Wright EJ; Fiser WP; Edens RE; Frazier EA; Morrow WR; Imamura M; Jaquiss RD
    J Heart Lung Transplant; 2007 Nov; 26(11):1163-9. PubMed ID: 18022083
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Anti-idiotypic antibodies specific for HLA in heart and kidney allograft recipients.
    Reed E; Ho E; Cohen DJ; Ramey W; Marboe C; D'Agati V; Rose EA; Hardy M; Suciu-Foca N
    Immunol Res; 1993; 12(1):1-11. PubMed ID: 8515181
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antibodies against tumor necrosis factor prolong cardiac allograft survival in the rat.
    Lin H; Chensue SW; Strieter RM; Remick DG; Gallagher KP; Bolling SF; Kunkel SL
    J Heart Lung Transplant; 1992; 11(2 Pt 1):330-5. PubMed ID: 1576139
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts.
    Wei RQ; Schwartz CF; Lin H; Chen GH; Bolling SF
    J Surg Res; 1999 Feb; 81(2):123-8. PubMed ID: 9927530
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys.
    Kawai T; Cosimi AB; Wee SL; Houser S; Andrews D; Sogawa H; Phelan J; Boskovic S; Nadazdin O; Abrahamian G; Colvin RB; Sach DH; Madsen JC
    Transplantation; 2002 Jun; 73(11):1757-64. PubMed ID: 12084998
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lung transplantation across donor-specific anti-human leukocyte antigen antibodies: utility of bortezomib therapy in early graft dysfunction.
    Stuckey LJ; Kamoun M; Chan KM
    Ann Pharmacother; 2012 Jan; 46(1):e2. PubMed ID: 22202499
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
    Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anti-donor HLA class I antibodies: pathways to endothelial cell activation and cell-mediated allograft rejection.
    Naemi FM; Carter V; Kirby JA; Ali S
    Transplantation; 2013 Aug; 96(3):258-66. PubMed ID: 23823649
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
    Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gene transfer of a soluble IL-1 type 2 receptor-Ig fusion protein improves cardiac allograft survival in rats.
    Simeoni E; Dudler J; Fleury S; Li J; Pagnotta M; Pascual M; von Segesser LK; Vassalli G
    Eur J Cardiothorac Surg; 2007 Feb; 31(2):222-8. PubMed ID: 17182252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.